Preferred Label : peptides;
MeSH definition : Members of the class of compounds composed of AMINO ACIDS joined together by peptide
bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES
are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately
13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized
on RIBOSOMES.; Members of the class of compounds composed of AMINO ACIDS joined together by peptide
bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES
are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately
13 or more amino acids. PROTEINS are considered to be larger versions of peptides
that can form into complex structures such as ENZYMES and RECEPTORS.;
MeSH synonym : Peptide;
MeSH hyponym : polypeptides; Polypeptide;
MeSH annotation : general; prefer specifics; fewer than 13 amino acids oligopeptides; primary structure
PROTEIN STRUCTURE, PRIMARY see AMINO ACID SEQUENCE; peptide structure other than primary:
coordinate IM with PROTEIN CONFORMATION or its specifics; general or unspecified; prefer specifics; fewer than 13 amino acids oligopeptides;
primary structure PROTEIN STRUCTURE, PRIMARY see AMINO ACID SEQUENCE; peptide structure
other than primary: coordinate with PROTEIN CONFORMATION or its specifics;
Wikipedia link : https://en.wikipedia.org/wiki/Peptide;
Is substance : O;
Members of the class of compounds composed of AMINO ACIDS joined together by peptide
bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES
are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately
13 or more amino acids. PROTEINS are linear polypeptides that are normally synthesized
on RIBOSOMES.
Members of the class of compounds composed of AMINO ACIDS joined together by peptide
bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES
are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately
13 or more amino acids. PROTEINS are considered to be larger versions of peptides
that can form into complex structures such as ENZYMES and RECEPTORS.
https://www.has-sante.fr/jcms/p_3283446/fr/lyxumia-10-20-microgrammes-lixisenatide
2021
false
false
false
France
evaluation of the transparency committee
lyxumia
lixisenatide
peptides
treatment outcome
insurance, health, reimbursement
hypoglycemic agents
diabetes mellitus, type 2
lixisenatide
injections, subcutaneous
Product containing only lixisenatide in parenteral dose form (medicinal product form)
Glucagon-Like Peptide-1 Receptor
lixisenatide
peptides
---
https://www.inesss.qc.ca/thematiques/medicaments/medicaments-evaluation-aux-fins-dinscription/extrait-davis-au-ministre/soliqua-5434.html
2020
false
false
false
Canada
French
insulin glargine and lixisenatide
drug evaluation
Insulin Glargine
drug combinations
diabetes mellitus, type 2
lixisenatide
peptides
---
https://www.has-sante.fr/portail/jcms/c_2877302/fr/bydureon
https://www.has-sante.fr/portail/jcms/c_2877302/fr/bydureon-exenatide-antidiabetique
2018
false
false
false
France
treatment outcome
drug therapy, combination
hypoglycemic agents
diabetes mellitus, type 2
insulin
metformin
exenatide
incretins
insurance, health, reimbursement
adult
Glycated Hemoglobin
injections, subcutaneous
guidelines for drug use
evaluation of the transparency committee
peptides
venoms
Exenatide
---
https://www.has-sante.fr/portail/jcms/c_2897004/en/bydureon
2018
false
false
false
France
exenatide
evaluation of the transparency committee
injections
suspension, nos
Set, Psychology
suspensions
injection, nos
device, nos
Complement
Injection moulding
long
devices
Grassland
equipment and supplies
peptides
venoms
Exenatide
---
https://www.has-sante.fr/portail/jcms/c_2768605/fr/parsabiv-etelcalcetide-agent-anti-parathyroidien
2017
false
false
false
France
French
English
treatment outcome
hyperparathyroidism, secondary
adult
injections, intravenous
hemodialysis
calcimimetic agents
calcimimetic agents
parathyroid hormone
renal insufficiency, chronic
peptides
peptides
etelcalcetide
guidelines for drug use
evaluation of the transparency committee
Hyperparathyroidism due to renal insufficiency (disorder)
comparative effectiveness research
etelcalcetide
etelcalcetide
renal dialysis
etelcalcetide hydrochloride
etelcalcetide hydrochloride
---
Summary Basis of Decision (SBD) for Adlyxine
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00363
2017
false
Canada
English
French
Glucagon-Like Peptide-1 Receptor
lixisenatide
canada
drug information
drug approval
treatment outcome
adult
diabetes mellitus, type 2
drug therapy, combination
hypoglycemic agents
injections, subcutaneous
lixisenatide
lixisenatide
peptides
peptides
---
https://www.has-sante.fr/portail/jcms/c_2752866/fr/revestive-teduglutide-analogue-de-synthese-du-glp-2
https://www.has-sante.fr/portail/jcms/c_2752866/fr/revestive
2017
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
teduglutide
teduglutide
short bowel syndrome
treatment outcome
parenteral nutrition
insurance, health, reimbursement
orphan drug production
injections, subcutaneous
continuity of patient care
Small Intestine Resection
risk management
drug monitoring
intestine, small
child
adolescent
teduglutide
glucagon-like peptide 2
peptides
peptides
---
http://www.riziv.fgov.be/SiteCollectionDocuments/consensus_litterature_resume_20161117.pdf
2016
false
false
false
Belgium
French
GLP-1 Mimetics
diabetes mellitus, type 2
review of literature
consensus
GLP-1 Mimetics
treatment outcome
albiglutide
albiglutide
Glucagon-like peptide-1 (GLP-1) analogues
drug therapy, combination
metformin
hypoglycemic agents
hypoglycemic agents
glimepiride
dulaglutide
dulaglutide
Liraglutide
Liraglutide
Sitagliptin Phosphate
sulfonylurea compounds
comparative effectiveness research
arterial pressure
insulin
thyroid neoplasms
pancreatitis
Injection Site Reaction
cardiovascular diseases
practice guidelines as topic
Evidence-Based medicine
rGLP-1 protein
rGLP-1 protein
glucagon-like peptide 1
glucagon-like peptide 1
glucagon-like peptide 1
immunoglobulin fc fragments
recombinant fusion proteins
glucagon-like peptides
glucagon-like peptides
immunoglobulin fc fragments
recombinant fusion proteins
glucagon-like peptides
peptides
venoms
peptides
venoms
thiazolidinediones
Pioglitazone
Exenatide
Exenatide
---
http://www.cochrane.org/fr/CD003993
2016
United Kingdom
France
French
french abstract
meta-analysis
peptides
neoplasms
treatment outcome
thymus extracts
adjuvants, immunologic
neoplasms
---
http://www.has-sante.fr/portail/jcms/c_2613509/fr/eptifibatide-accord
2016
false
false
false
false
France
French
evaluation of the transparency committee
drugs, generic
Eptifibatide 750micrograms/mL infusion solution 100mL vial (product)
Eptifibatide 2mg/mL injection solution 10mL vial (product)
eptifibatide
peptides
Eptifibatide
---
Eptifibatide Accord - eptifibatide
https://www.ema.europa.eu/medicines/human/EPAR/eptifibatide-accord
2016
false
United Kingdom
French
English
syndication feed
drugs, generic
drug interactions
pregnancy
breast feeding
drug therapy, combination
infusions, intravenous
injections, intravenous
recurrence
Eptifibatide 2mg/mL injection solution 10mL vial (product)
Eptifibatide 750micrograms/mL infusion solution 100mL vial (product)
Product containing eptifibatide (medicinal product)
peptides
adult
myocardial infarction
angina, unstable
platelet aggregation inhibitors
treatment outcome
drug evaluation, preclinical
eptifibatide
peptides
drug evaluation
package leaflet
summary of product characteristics
Eptifibatide
Eptifibatide
---
https://www.ema.europa.eu/medicines/human/EPAR/Parsabiv
2016
false
false
false
United Kingdom
French
English
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
treatment outcome
hyperparathyroidism, secondary
adult
injections, intravenous
hemodialysis
calcimimetic agents
calcimimetic agents
parathyroid hormone
drug interactions
pregnancy
breast feeding
product surveillance, postmarketing
renal insufficiency, chronic
peptides
peptides
drug evaluation, preclinical
etelcalcetide
etelcalcetide
etelcalcetide
renal dialysis
etelcalcetide hydrochloride
etelcalcetide hydrochloride
---
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00267
2015
false
false
false
false
Canada
French
drug information
Product containing teduglutide in parenteral dose form (medicinal product form)
teduglutide
teduglutide
peptides
---
http://www.has-sante.fr/portail/jcms/c_2007289/fr/revestive-teduglutide-analogue-de-synthese-du-glp-2
2015
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
teduglutide
teduglutide
short bowel syndrome
treatment outcome
adult
parenteral nutrition
insurance, health, reimbursement
orphan drug production
injections, subcutaneous
continuity of patient care
Small Intestine Resection
adaptation, physiological
risk management
drug monitoring
intestine, small
teduglutide
glucagon-like peptide 2
peptides
peptides
---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=66105532
2015
false
false
false
France
French
summary of product characteristics
package leaflet
evaluation of the transparency committee
peptides
venoms
Exenatide
---
http://unt-ori2.crihan.fr/unspf/2014_Rennes_Tomasi_polypeptides
2015
false
true
true
France
French
educational course
anti-bacterial agents
colistin
colistin
colistin
colistin
polymyxin B
bacitracin
education, pharmacy
polypeptides
peptides
Contraindications, Drug
---
http://www.has-sante.fr/portail/jcms/c_2582560/fr/revestive
http://www.has-sante.fr/portail/jcms/c_2007289/fr/revestive
2015
false
false
false
France
French
evaluation of the transparency committee
teduglutide
teduglutide
short bowel syndrome
treatment outcome
adult
parenteral nutrition
insurance, health, reimbursement
orphan drug production
injections, subcutaneous
continuity of patient care
Small Intestine Resection
adaptation, physiological
risk management
drug monitoring
intestine, small
teduglutide
glucagon-like peptide 2
peptides
peptides
---
http://www.has-sante.fr/portail/jcms/c_2000727/fr/bydureon
2014
false
false
false
France
French
evaluation of the transparency committee
guidelines for drug use
diabetes mellitus, type 2
treatment outcome
injections, subcutaneous
hypoglycemic agents
hypoglycemic agents
Delayed-Action preparations
glucagon-like peptide 1
drug therapy, combination
adult
Pre-filled Pen Syringe
insurance, health, reimbursement
exenatide
peptides
venoms
peptides
venoms
Exenatide
Exenatide
---
http://medecine-pharmacie.univ-rouen.fr/jsp/saisie/liste_fichiergw.jsp?OBJET=DOCUMENT&CODE=1188826354725&LANGUE=0
2014
false
false
false
false
France
educational course
amino acids
carbohydrate biochemistry
lipids
proteins
peptides
---
http://www.has-sante.fr/portail/jcms/c_1778488/fr/byetta
http://www.has-sante.fr/portail/jcms/c_517640/fr/byetta?xtmc=&xtcr=2
2014
false
false
false
France
French
evaluation of the transparency committee
drug therapy, combination
metformin
incretins
incretins
insulin
hypoglycemic agents
hypoglycemic agents
treatment outcome
insurance, health, reimbursement
diabetes mellitus, type 2
adult
injections, subcutaneous
exenatide
peptides
venoms
peptides
venoms
Exenatide
Exenatide
---
http://www.has-sante.fr/portail/jcms/c_2038301/fr/byetta
2014
false
false
false
France
French
evaluation of the transparency committee
drug therapy, combination
metformin
incretins
incretins
insulin
hypoglycemic agents
hypoglycemic agents
treatment outcome
insurance, health, reimbursement
diabetes mellitus, type 2
adult
injections, subcutaneous
Sulfonylurea Antidiabetic Agent
sulfonylurea compounds
exenatide
peptides
venoms
peptides
venoms
Exenatide
Exenatide
---
https://minerva-ebp.be/fr/article/102
2013
false
false
minerva-ebm.be
Belgium
French
diabetes mellitus, type 2
critical appraisal or critical reading
hypoglycemic agents
treatment outcome
peptides
venoms
sulfonylurea compounds
---
http://archives.uness.fr/sites/unf3s/media/paces/Grenoble_1112/seve_michel/seve_michel_p17/seve_michel_p17.pdf
http://archives.uness.fr/sites/unf3s/media/paces/Grenoble_1112/seve_michel/seve_michel_p17/index.htm
2012
false
true
false
true
PACES / bac 1
France
French
educational course
biochemistry
peptides
proteins
---
https://www.ema.europa.eu/medicines/human/EPAR/Byetta
2012
false
United Kingdom
French
English
syndication feed
Glucagon-Like Peptide-1 Receptor
exenatide
aged
drug interactions
pregnancy
breast feeding
peptides
venoms
hypoglycemic agents
diabetes mellitus, type 2
drug evaluation, preclinical
drug storage
drug approval
drug labeling
peptides
hypoglycemic agents
venoms
treatment outcome
injections, subcutaneous
drug therapy, combination
adult
drug evaluation
summary of product characteristics
package leaflet
Exenatide
Exenatide
---
https://www.ema.europa.eu/medicines/human/EPAR/Integrilin
2012
false
United Kingdom
French
English
syndication feed
peptides
adult
myocardial infarction
angina, unstable
platelet aggregation inhibitors
treatment outcome
drug evaluation
eptifibatide
peptides
drug evaluation
package leaflet
summary of product characteristics
Eptifibatide
---
http://www.orpha.net/consor/cgi-bin/OC_Exp.php?Lng=FR&Expert=100007
2011
France
scientific and technical information
peptides
amyloid
problem-based learning
vascular diseases
amyloid angiopathy
---
https://rmlg.uliege.be/article/1973
2009
Belgium
journal article
medicine in literature
dentistry
review literature
peptides
anti-infective agents
review literature as topic
---
https://minerva-ebp.be/fr/article/540
2008
false
false
minerva-ebm.be
Belgium
French
diabetes mellitus, type 2
drug therapy, combination
treatment outcome
hypoglycemic agents
peptides
venoms
peptides
venoms
critical appraisal or critical reading
Exenatide
---
https://www.jle.com/fr/revues/bio_rech/vir/e-docs/00/04/36/EE/resume.md?type=text.html
2007
France
journal article
fever
virology
foot-and-mouth disease virus
peptides
---
http://www.has-sante.fr/portail/display.jsp?id=c_398670
2003
France
French
enteral nutrition
malnutrition
peptides
health technology assessment
treatment outcome
---
ATC code(s)
